Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance.
- NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_assertion description "[Though C-C chemokine ligand 2 (CCL2) has been shown to play a pivotal role in prostate cancer tumorigenesis and invasion, the role of inherited variation in the CCL2 gene in prostate cancer progression and metastases remains unanswered.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance.
- NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_assertion evidence source_evidence_literature NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance.
- NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_assertion SIO_000772 21135144 NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance.
- NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_assertion wasDerivedFrom befree-20140225 NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance.
- NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_assertion wasGeneratedBy ECO_0000203 NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP570349.RAbyysUucDQ2eP7Jk3EH723PRNLMUVs8Z3PdpY-DhCpDU130_provenance.